🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to characterize and compare the pharmacokineti...
Status
Completed
Location
Clinical Research Center Hadassah Ein Kerem Medical Center
Start Date
2023-05-11
Trial ID
NCT05965167
This study compares how effective is the molecular screening (a blood test)...
Status
Recruiting
Location
Consultorio Médico TIMSER
Start Date
2026-02-03
Trial ID
NCT07480902
This is a study of combination direct-acting antiviral agents (DAA) with or...
Status
Completed
Location
Site Reference ID/Investigator# 57583
Start Date
2011-10
Trial ID
NCT01464827
This is a Phase I, multi-center, Dose-Escalating, Safety Study of an Intrav...
Status
Completed
Location
Rambam Health Care Campus
Start Date
2012-10
Trial ID
NCT01705002
Treatments Being Tested
* The study is evaluating the safety and tolerability of Nivolumab (BMS-936...
Status
Completed
Location
Ucla
Start Date
2011-12-16
Trial ID
NCT01454102
Treatments Being Tested
The aim of this study is to evaluate the safety and immunogenicity of a hum...
Status
Active Not Recruiting
Location
Velocity Clinical Research, Phoenix- Site Number : 8400025
Start Date
2024-11-11
Trial ID
NCT06686654
This is a prospective, open-label, phase 2 platform trial. The purpose of t...
Status
Recruiting
Location
Breast cancer institute of Fudan University Cancer Hospital
Start Date
2024-10-21
Trial ID
NCT06649331
Grps 1, 2, 3 "This study will be testing the performance of ASV and DCV ped...
Status
Completed
Location
Multiple Locations
Start Date
2014-12
Trial ID
NCT02323594
Treatments Being Tested
This prospective study of 60 slides of basal and squamous cell carcinomas o...
Status
Completed
Location
Abramsonc Cancer Center of the University of Pennsylvania
Start Date
2012-02
Trial ID
NCT01540695
The study assesses the efficacy of neoadjuvant treatment with pyrotinib and...
Status
Unknown
Location
the First Affiliated Hospital of Nanjing Medical University
Start Date
2021-06-03
Trial ID
NCT04717531
Treatments Being Tested